CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹17 Cr | ₹22 Cr | ₹18 Cr |
What is the latest Net Current Assets ratio of CONCORD DRUGS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹18 Cr |
How is Net Current Assets of CONCORD DRUGS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -11.69 | |
| Mar2024 | ₹17 Cr | -24.40 | |
| Mar2023 | ₹22 Cr | 19.72 | |
| Mar2022 | ₹18 Cr | - | |
Compare Net Current Assets of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹104.3 Cr | 10.4% | 16.3% | 53.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 10.4% |
16.3% |
53.4% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses